Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × fezolinetant × Clear all

Phase

Status

Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Cyclophosphamide 216 Radiotherapy 190 Carboplatin 160 Gemcitabine 155 Cisplatin 155 Docetaxel 141 Bevacizumab 141 Paclitaxel 126 Capecitabine 125 Rituximab 121 pembrolizumab 119 Nivolumab 107 Dexamethasone 107 Oxaliplatin 106 Fluorouracil 101 fludarabine 91 Doxorubicin 89 Radiosurgery 85 Lenalidomide 85 fludarabine phosphate 84 Etoposide 84 Irinotecan 83 Cytarabine 83 Filgrastim 81 Leucovorin 78 Radiation 77 Magnetic Resonance Spectroscopy 76 Bortezomib 74 Temozolomide 68 Pemetrexed 67

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06617455 2026-03-02

VEnT

University of Michigan Rogel Cancer Center

Phase 2 Terminated

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡